Multi-center, single-blind randomized controlled trial comparing functional electrical stimulation therapy to conventional therapy in incomplete tetraplegia.
functional electrical simulation (FES)
rehabilation
spinal cord injury
tetraplegia
therapy
Journal
Frontiers in rehabilitation sciences
ISSN: 2673-6861
Titre abrégé: Front Rehabil Sci
Pays: Switzerland
ID NLM: 9918227358906676
Informations de publication
Date de publication:
2022
2022
Historique:
received:
15
07
2022
accepted:
25
08
2022
entrez:
3
10
2022
pubmed:
4
10
2022
medline:
4
10
2022
Statut:
epublish
Résumé
Loss of upper extremity function after tetraplegia results in significant disability. Emerging evidence from pilot studies suggests that functional electrical stimulation (FES) therapy may enhance recovery of upper extremity function after tetraplegia. The aim of this trial was to determine the effectiveness of FES therapy delivered by the Myndmove stimulator in people with tetraplegia. A multi-center Between June 2019 to August 2021, 51 participants were randomized to FES ( Forty sessions of FES therapy delivered by the MyndMove stimulator are as effective as conventional therapy in producing meaningful functional improvements that persist after therapy is completed. Limitations of this study include the impact of COVID-19 limiting the ability to recruit the target sample size and per-protocol execution of the study in one-third of the participants. This trial is registered at www.ClinicalTrials.gov, NCT03439319.
Sections du résumé
Background
UNASSIGNED
Loss of upper extremity function after tetraplegia results in significant disability. Emerging evidence from pilot studies suggests that functional electrical stimulation (FES) therapy may enhance recovery of upper extremity function after tetraplegia. The aim of this trial was to determine the effectiveness of FES therapy delivered by the Myndmove stimulator in people with tetraplegia.
Methods
UNASSIGNED
A multi-center
Results
UNASSIGNED
Between June 2019 to August 2021, 51 participants were randomized to FES (
Conclusion
UNASSIGNED
Forty sessions of FES therapy delivered by the MyndMove stimulator are as effective as conventional therapy in producing meaningful functional improvements that persist after therapy is completed. Limitations of this study include the impact of COVID-19 limiting the ability to recruit the target sample size and per-protocol execution of the study in one-third of the participants.
Registration
UNASSIGNED
This trial is registered at www.ClinicalTrials.gov, NCT03439319.
Identifiants
pubmed: 36188946
doi: 10.3389/fresc.2022.995244
pmc: PMC9500231
doi:
Banques de données
ClinicalTrials.gov
['NCT03439319']
Types de publication
Journal Article
Langues
eng
Pagination
995244Subventions
Organisme : RRD VA
ID : I50 RX001871
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR003168
Pays : United States
Informations de copyright
© 2022 Anderson, Korupolu, Musselman, Pierce, Wilson, Yozbatiran, Desai, Popovic and Thabane.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Neurotrauma. 2004 Oct;21(10):1371-83
pubmed: 15672628
Top Spinal Cord Inj Rehabil. 2012 Spring;18(2):167-86
pubmed: 23459270
Spinal Cord. 1997 Dec;35(12):850-6
pubmed: 9429264
Arch Phys Med Rehabil. 1997 Jun;78(6):608-14
pubmed: 9196468
Arch Phys Med Rehabil. 2008 Apr;89(4):602-8
pubmed: 18373988
Arch Phys Med Rehabil. 1999 Mar;80(3):299-304
pubmed: 10084438
J Neurotrauma. 2016 Feb 1;33(3):307-14
pubmed: 26560017
Arch Phys Med Rehabil. 2011 Mar;92(3):369-75
pubmed: 21353821
Spinal Cord. 2000 Apr;38(4):244-9
pubmed: 10822395
J Neurotrauma. 2008 Jun;25(6):677-85
pubmed: 18578636
J Neurotrauma. 2017 May 1;34(9):1726-1743
pubmed: 27809702
Top Spinal Cord Inj Rehabil. 2013 Fall;19(4):279-87
pubmed: 24244093
BMJ Open. 2020 Sep 28;10(9):e039650
pubmed: 32988951
Disabil Rehabil. 2013 Oct;35(21):1808-13
pubmed: 23343359
Neurorehabil Neural Repair. 2008 Nov-Dec;22(6):706-14
pubmed: 18971385
Spinal Cord. 2006 Mar;44(3):143-51
pubmed: 16130018
Spinal Cord. 2005 Jan;43(1):1-13
pubmed: 15289804
J Neurotrauma. 2012 Mar 20;29(5):905-14
pubmed: 21568688
Disabil Rehabil. 2007 Dec 30;29(24):1926-33
pubmed: 17852230
Top Spinal Cord Inj Rehabil. 2018 Summer;24(3):227-238
pubmed: 29997426
Front Med Biol Eng. 1992;4(4):241-55
pubmed: 1476953
J Spinal Cord Med. 2014 Nov;37(6):734-43
pubmed: 24968955
Neurorehabil Neural Repair. 2011 Jun;25(5):433-42
pubmed: 21304020
Arch Phys Med Rehabil. 1990 May;71(6):415-21
pubmed: 2334287